Head-to-head · WeighScore
AskRx vs Found
By GLP-1 ScorecardUpdated
Score comparison
Found has the higher recorded score — 83.5/100 to 55.8/100.
Found grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Found offers compounded, brand-name and oral GLP-1 routes, but their bills differ: compounded plans include medication and care, while branded medication and labs cost extra.
Before you choose
AskRx does not publish a semaglutide price, so its AskRx review sets out what it does disclose, while the Found review explains the conditions attached to Found's figure. The semaglutide cost page compares published rates across the field. Ask AskRx for a written total before treating either one as the cheaper choice.
If neither one fits, AskRx vs Navio MD and BeyondMD vs Found compare each of them with another graded program, and the list of alternatives to AskRx ranks the programs closest to AskRx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | AskRx | Found |
|---|---|---|
| WeighScore | 55.8/100 | 83.5/100 |
| Grade | C | B |
| Site position | #462 | #7 |
| Semaglutide | Medication extra; confirm pharmacy and total | $149 first, then $269 every 28 days on the one-term cash compounded plan (labs extra; confirm selected terms) |
| Tirzepatide | Medication extra; confirm pharmacy and total | $199 first, then $339 every 28 days on the one-term cash compounded plan (labs extra; confirm selected terms) |
| Coverage | All 50 states advertised; video available in select states | U.S. service with state, treatment and insurance restrictions; confirm your eligibility |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Strengths
- Advertises Wegovy injection and tablets and Zepbound
- Breaks out the advertised physician and fulfillment fees
What to consider
- Medication is extra
- Homepage and terms disagree about who dispenses and collects payment
- Initial subscription refunds are discretionary and subject to conditions
Strengths
- Current compounded offers include medication, membership and care, with separate semaglutide and tirzepatide price tables
- Branded injection and oral options are listed, subject to prescription, stock and patient-specific terms
- Insurance-track clinical visits and cash-pay care are distinguished in the public billing documents
- Terms name possible independent medical groups and describe check-ins and messaging
What to consider
- Cash compounded renewal rates differ by molecule and recur every 28 days, not a calendar month
- Longer-term advertised rates and upfront-payment wording do not settle the selected charge or supply
- Labs cost extra; insurance-track cost-sharing can add to the bill and does not reimburse compounded-medication fees
- Refund wording about three days and the first consultation conflicts; rejection of a preferred GLP-1 is not disqualification from all treatment
- The assigned compounder, actual treating practice and individual license status remain unresolved
- A brand or oral menu listing does not establish a specific available prescription, complete price or clinical equivalence
Featured provider
Found
Factor scores not reassessed.Found scores 83.5/100 (B). Found offers compounded, brand-name and oral GLP-1 routes, but their bills differ: compounded plans include medication and care, while branded medication and labs cost extra.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.